Cellastra, Inc.

📍 San Francisco, United States🗓 Founded 2005👥 6 employees💰 Last funded Jan 2017
Biotechnology Research🌐 cellastra.com
Website LinkedIn
ENCODING SCARLESS HEALING TARGETING UNMED NEEDS IN RESPIRATORY INFECTIONS/COVID-19, WOMEN'S HEALTH, AESTHETIC SUFRGERY & BURN CARE Cellastra Inc., a developer of disruptive gene therapies, is a private biotech company based in the San Francisco Financial District. It was founded and managed by proven industry executives with a track record of execution. Cellastra’s mission is to develop Disruptive, First or Best in Class Gene Therapies. Cellastra Proprietary Technology - Gene Vector- Anti-scarring peptide: Cellastra is developing viral gene vector-mediated intervention to address an area of great unmet medical needs in scarless wound healing after surgery and respiratory infections: 1. Surgery: Prevent excessive dermal scarring, e.g., after breast augmentation surgery, and C section. 2. Respiratory Infections: Prevent an excessive immune response, tissue damage, and scarring/fibrosis in high-risk patient groups with respiratory infections such as COVID-19 (coronavirus disease 2019) and RSV (respiratory syncytial virus). Scarless wound healing can be achieved by using a gene vector encoding for endogenous continuous production of the anti-scarring peptides at the site of injury. Thus, two gene vectors are planned for development (Cellexa applied under the skin after surgery and Virexa inhaled into the lungs in COVID-19 and other respiratory infections). The development of these vectors is built and expands upon a foundation of scientific proof of concept data of the anti-scarring peptide ensereptide.For more information see link to website,
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2005
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in Cellastra, Inc.?
Cellastra, Inc. has 1 investors on record on gritt.io.
When did Cellastra, Inc. last raise funding?
The most recent investment in Cellastra, Inc. recorded on gritt.io was in January 2017.
When was Cellastra, Inc. founded?
Cellastra, Inc. was founded in 2005.
What industry is Cellastra, Inc. in?
Cellastra, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cellastra, Inc. based?
Cellastra, Inc. is headquartered in San Francisco, United States.